日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors

一项针对晚期实体瘤患者的SHP2抑制剂BBP-398的首次人体I期研究

Falchook, Gerald; Braganca Xavier, Camila; Van Veenhuyzen, David; Malhotra, Jyoti; Sadeghi, Saeed; Kalebasty, Arash Rezazadeh; Wood, Lauren; Rahman, Faisal; Li, Elizabeth; Pak, Yvonne; Khalil, Maya; Spira, Alexander I; Sommerhalder, David; Garrido-Laguna, Ignacio; Hong, David S

De Novo high-volume metastatic prostate cancer with primary resistance to standard systemic therapy and exceptional response to PSMA-Lu177: A case report

一例原发性高肿瘤转移性前列腺癌,对标准全身治疗有原发性耐药,但对PSMA-Lu177治疗反应极佳:病例报告

Rafizadeh, Desiree; Kaakour, D; Sun, S; Herman, J; Kain, T; Kalebasty, A Rezazadeh

Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancer

对脐尿管癌可靶向突变和肿瘤微环境的综合分析

Benjamin, David J; Adeyelu, Tolulope T; Elliott, Andrew; Darabi, Sourat; Lee, Thomas; McKay, Rana R; Oberley, Matthew J; Rezazadeh Kalebasty, Arash

Genes Encoding Multiple Modulators of the Immune Response Are Methylated in the Prostate Tumor Microenvironment of African Americans

在非裔美国人的前列腺肿瘤微环境中,编码多种免疫反应调节因子的基因发生甲基化。

Kumar, Vinay; Jennings, Tara Sinta Kartika; Ueta, Lucas; Nguyen, James; Song, Liankun; McClelland, Michael; Chu, Weiping; Lilly, Michael; Ittmann, Michael; Castro, Patricia; Kalebasty, Arash Rezazadeh; Mercola, Dan; Yazdanpanah, Omid; Zi, Xiaolin; Rahmatpanah, Farah

A decade review of mental health monitoring in clinical trials for United States Food and Drug Administration-approved genitourinary cancer treatments

对美国食品药品监督管理局批准的泌尿生殖系统癌症治疗临床试验中心理健康监测的十年回顾

Teymouri, Farzad; Jabbari, Parnian; Yazdanpanah, Omid; Mahadevan, Aditya; Rezazadeh Kalebasty, Arash; Benjamin, David J

Vitamin D deficiency in prostate cancer: Prevalence in a sun-rich climate and influence of androgen deprivation therapy

前列腺癌患者维生素D缺乏症:在阳光充足气候下的患病率及雄激素剥夺疗法的影响

Hasan, Nazmul; Rafizadeh, Desiree; Gibson, Spencer; Kaakour, Dalia; Lee, Benjamin; Khaleghi, Barbod; Yazdanpanah, Omid; Rezazadeh Kalebasty, Arash

The Role of Ayurveda in Prostate Cancer Management

阿育吠陀在治疗前列腺癌中的作用

Jabbari, Parnian; Yazdanpanah, Omid; Benjamin, David J; Rezazadeh Kalebasty, Arash

A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy

TROPHY-U-01 研究(队列 2)简明摘要:在无法接受顺铂类化疗的转移性尿路上皮癌患者中,免疫治疗后使用 sacituzumab govitecan 的疗效

Grivas, Petros; Tagawa, Scott T; Jain, Rohit K; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P; Davis, Nancy; Sternberg, Cora N; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann

Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report

伊普他考泮治疗C5阻滞剂难治性非典型溶血性尿毒综合征合并卡斯尔曼病:病例报告

Nguyen, Matthew D; Ciurea, Stefan; Desai, Sheetal; Kalebasty, Arash Rezazadeh; Tran, Minh-Ha; Gee, Caroline; Tadros, Mina; Nguyen, Vu Q; Patel, Samir; Selamet, Umut; Hanna, Ramy

Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data

评估转移性肾细胞癌患者对酪氨酸激酶抑制剂的依从性和持续性:一项基于真实世界数据的回顾性分析

Arter, Zhaohui Liao; Benjamin, David J; Cao, Yen; Farias, Jorge; Thirumaran, Ranjit Kumar; Forsyth, Michael; Mar, Nataliya; Rezazadeh Kalebasty, Arash